Qazvin Medical Science University
Qazvin, Qazvin Province, 3419759811, Iran
NCT Number: NCT01572805
The purpose of this study is to assess the effect of melatonin on pain and amount of blood loss after cesarean delivery one hundred twenty women with singleton term pregnancy undergoing elective or emergency lower segment cesarean section under spinal anesthesia were included in this study. The patients were randomly allocated to one of three groups of 40 each to receive sublingual 3 mg melatonin or 6 mg melatonin or placebo before spinal of anesthesia . In all patients 20 IU syntocinon which dissolved in 0.5liter of lactated Ringer's solution) at the rate of 500 ml over a 15 minutes period, immediately after delivery of the neonate was infused . Time to first requirement of analgesic supplement, Hemodynamic variables,will be recorded.Patients were instructed preoperatively in the use of the verbal rating scale (VRS) from 0 to 10 (0no pain, 10maximum imaginable pain) for pain assessment. If the VRS exceeded four and the patient requested a supplement analgesic, diclofenac Na supp 100 mg was to be given for post-operative pain relief as needed . For breakthrough pain(VRS >4) if time of administration of diclofenac Na less than 8h,Pethidine 25 mg IV was given. For determination of blood loss ,change in hemoglobin levels, need for additional oxytocics and ,the volume of blood in the suction bottle was measured, blood soaked sponges. Hemoglobin values were determined both before surgery and 12 h following surgery
Looking for future studies?
Notify Me18 year–42 year
Female
Interventional
Phase 1 / Phase 2
Qazvin, Qazvin Province, 3419759811, Iran
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To receive sublingual 3 mg melatonin before spinal of anesthesia .
To receive sublingual 6 mg melatonin before spinal of anesthesia .
To receive sublingual placebo tablet before spinal of anesthesia .
Time frame: Time to first requirement of analgesic supplement within 24 hours after intratechal injection
Time frame: during surgery
Time frame: 5min before the intrathecal injection,and at 2, 4, 6, 10, 15,20 min after the injection
Qazvin University Of Medical Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03805607
Agnosia, Analgesia, Obstetrical
Boston, Massachusetts, United States
View Trial DetailsNCT03475342
Anemia, Female Urogenital Diseases and Pregnancy Complications
Akure, Nigeria
View Trial DetailsNCT02509312
Agnosia, Analgesia, Obstetrical
Cleveland, Ohio, United States
View Trial DetailsNCT01786330
Female Urogenital Diseases and Pregnancy Complications, Hemorrhage
Wichita, Kansas, United States
View Trial Details